<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots

PremiumThe Fly

8d ago

PremiumThe Fly

Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads

10d ago

Omnicom, WPP under pressure after Trump moves to regulate pharma ads

PremiumThe Fly

10d ago

Trump Trade: U.S. President signs new pharma order

BMY

PremiumThe Fly

10d ago

PremiumThe FlyTrump signs memorandum mandating pharma ads give more info on risks

10d ago

BMY

Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market

Ratings

Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market

12d ago

Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley

The Fly

Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley

12d ago

Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher

PremiumThe Fly

16d ago

Piper says competitor AD data reinforces Nektar’s REZPEG differentiated profile

AMGN

PremiumThe Fly

16d ago

Salesforce slides, Figma flops after earnings: Morning Buzz

NKTR

PremiumThe Fly

16d ago

PremiumThe Fly

Video: Regeneron getting boost from competitor ‘disappointing’ data

16d ago

REGN

PremiumThe FlySanofi’s ‘disappointing’ results to boost Regeneron shares, says Raymond James

16d ago

AMGN

Nektar jumps after Sanofi data misses expectations

The Fly

Nektar jumps after Sanofi data misses expectations

16d ago

NKTR

Sanofi amlitelimab data ‘well short of investor expectations,’ says BofA

The Fly

Sanofi amlitelimab data ‘well short of investor expectations,’ says BofA

16d ago

Sanofi says amlitelimab met primary, key secondary endpoints in Phase 3 study

PremiumThe Fly

16d ago

Florida surgeon general says state will eliminate vaccine mandates

PremiumThe Fly

17d ago

GSK

PFE

PremiumThe Fly

Sanofi upgraded to Buy from Hold at Deutsche Bank

18d ago

FDA approves Sanofi’s Wayrilz as BTK inhibitor for immune thrombocytopenia

PremiumThe Fly

21d ago

PremiumThe FlyNovavax 2025-2026 Formula COVID-19 vaccine approved in U.S.

24d ago

NVAX

Buy/Sell: Wall Street’s top 10 stock calls this week

The Fly

Buy/Sell: Wall Street’s top 10 stock calls this week

29d ago

CVS

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment

Company Announcements

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment

29d ago